[1]
C. Bektur and T. Nurgozhin, “Cost-effectiveness Analysis of Denosumab in the Prevention of Skeletal-related Events in Patients with Prostate Cancer in Kazakhstan”, cajgh, vol. 3, Dec. 2014.